8.8
CVE-2020-14490
- EPSS 0.21%
- Veröffentlicht 29.07.2020 13:15:10
- Zuletzt bearbeitet 21.11.2024 05:03:23
- Quelle ics-cert@hq.dhs.gov
- CVE-Watchlists
- Unerledigt
OpenClinic GA 5.09.02 and 5.89.05b includes arbitrary local files specified within its parameter and executes some files, which may allow disclosure of sensitive files or the execution of malicious uploaded files.
Daten sind bereitgestellt durch National Vulnerability Database (NVD)
Openclinic Ga Project ≫ Openclinic Ga Version5.09.02
Openclinic Ga Project ≫ Openclinic Ga Version5.89.05b
| Typ | Quelle | Score | Percentile |
|---|---|---|---|
| EPSS | FIRST.org | 0.21% | 0.428 |
| Quelle | Base Score | Exploit Score | Impact Score | Vector String |
|---|---|---|---|---|
| nvd@nist.gov | 8.8 | 2.8 | 5.9 |
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
|
| nvd@nist.gov | 6.5 | 8 | 6.4 |
AV:N/AC:L/Au:S/C:P/I:P/A:P
|
| ics-cert@hq.dhs.gov | 8.8 | 2.8 | 5.9 |
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
|
CWE-22 Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory.